Host defense, viruses and apoptosis
暂无分享,去创建一个
[1] M. Oren,et al. p53 and apoptosis. , 2007, Seminars in cancer biology.
[2] G. Barber,et al. Oncolytic Activity of Vesicular Stomatitis Virus Is Effective against Tumors Exhibiting Aberrant p53, Ras, or Myc Function and Involves the Induction of Apoptosis , 2001, Journal of Virology.
[3] G. Stark,et al. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene , 2000, The EMBO journal.
[4] G. Barber,et al. Vesicular Stomatitis Virus (VSV) Therapy of Tumors , 2000, IUBMB life.
[5] N. Kadowaki,et al. Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity , 2000, The Journal of experimental medicine.
[6] Robert L Moritz,et al. Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.
[7] Xiaodong Wang,et al. Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.
[8] C. Balagué,et al. Replicative adenoviruses for cancer therapy , 2000, Nature Biotechnology.
[9] Nahum Sonenberg,et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus , 2000, Nature Medicine.
[10] Y. E. Chin,et al. Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB Activation , 2000, Molecular and Cellular Biology.
[11] P. Roberts,et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. , 2000, Immunity.
[12] E. Kieff,et al. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Strom,et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.
[14] K. Vousden,et al. Role of NF-κB in p53-mediated programmed cell death , 2000, Nature.
[15] J. Hiscott,et al. The IRF-3 Transcription Factor Mediates Sendai Virus-Induced Apoptosis , 2000, Journal of Virology.
[16] M. Kelliher,et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. , 2000, Immunity.
[17] C. Gélinas,et al. The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-xL , 2000, Molecular and Cellular Biology.
[18] A. Polack,et al. Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. , 2000, Blood.
[19] C. Trautwein,et al. NFκB Mediates Apoptosis through Transcriptional Activation of Fas (CD95) in Adenoviral Hepatitis* , 2000, The Journal of Biological Chemistry.
[20] K. Takeuchi,et al. Sendai Virus Blocks Alpha Interferon Signaling to Signal Transducers and Activators of Transcription , 2000, Journal of Virology.
[21] P. Roberts,et al. Alpha/Beta Interferons Potentiate Virus-Induced Apoptosis through Activation of the FADD/Caspase-8 Death Signaling Pathway , 2000, Journal of Virology.
[22] T. Steele,et al. Recent developments in the virus therapy of cancer. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[23] K. Früh,et al. A role for MHC class I down‐regulation in NK cell lysis of herpes virus‐infected cells , 2000, European journal of immunology.
[24] G. Nabel,et al. p53 inhibition by the LANA protein of KSHV protects against cell death , 1999, Nature.
[25] A. Lazzarin,et al. Constitutive activation of STATs upon in vivo human immunodeficiency virus infection. , 1999, Blood.
[26] R. Zinkernagel,et al. Control of early viral and bacterial distribution and disease by natural antibodies. , 1999, Science.
[27] M. Karin,et al. JNK2 and IKKbeta are required for activating the innate response to viral infection. , 1999, Immunity.
[28] B. Seed,et al. Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. , 1999, Immunity.
[29] H. Drexler,et al. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease , 1999, Oncogene.
[30] B. Williams,et al. PKR; a sentinel kinase for cellular stress , 1999, Oncogene.
[31] L. Boise,et al. Azidothymidine and Interferon-α Induce Apoptosis in Herpesvirus-associated Lymphomas , 1999 .
[32] L. Hood,et al. Modulation of the NF-κB pathway by virally encoded Death Effector Domains-containing proteins , 1999, Oncogene.
[33] J. M. Lee,et al. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] I. Wang,et al. Regulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding Protein , 1999, The Journal of experimental medicine.
[35] W. Wold,et al. Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. , 1999, Current opinion in immunology.
[36] C. Biron. Initial and innate responses to viral infections--pattern setting in immunity or disease. , 1999, Current opinion in microbiology.
[37] S. Fulda,et al. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[38] E. Podack. How to induce involuntary suicide: the need for dipeptidyl peptidase I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Peschon,et al. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. , 1999, Journal of immunology.
[40] J. Xaus,et al. Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. , 1999, Immunity.
[41] R. Verdijk,et al. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. , 1999, Journal of immunology.
[42] S. Korsmeyer,et al. Inhibition of virus-induced neuronal apoptosis by Bax , 1999, Nature Medicine.
[43] M. Esteban,et al. Induction of Apoptosis by Double-Stranded-RNA-Dependent Protein Kinase (PKR) Involves the α Subunit of Eukaryotic Translation Initiation Factor 2 and NF-κB , 1999, Molecular and Cellular Biology.
[44] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[45] G. Nolan,et al. NF-κB to the rescue: RELs, apoptosis and cellular transformation , 1999 .
[46] K. Okumura,et al. Type I Interferons (IFNs) Regulate Tumor Necrosis Factor–related Apoptosis-inducing Ligand (TRAIL) Expression on Human T Cells: A Novel Mechanism for the Antitumor Effects of Type I IFNs , 1999, The Journal of experimental medicine.
[47] T. Akaike,et al. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. , 1999, Biochemical and biophysical research communications.
[48] D. Rebouillat,et al. The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[49] H. Horvitz,et al. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. , 1999, Cancer research.
[50] L. Owen-Schaub,et al. Activation-Dependent Transcriptional Regulation of the Human fas Promoter Requires NF-κB p50-p65 Recruitment , 1999, Molecular and Cellular Biology.
[51] S. Bartz,et al. Human Immunodeficiency Virus Type 1 Tat Induces Apoptosis and Increases Sensitivity to Apoptotic Signals by Up-Regulating FLICE/Caspase-8 , 1999, Journal of Virology.
[52] Hanno Langen,et al. Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA , 1999, The Journal of experimental medicine.
[53] M. Tomonaga,et al. Fas Antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-γ and tumor necrosis factor-α and potentiates apoptotic death , 1999 .
[54] G. Salvesen. Programmed cell death and the caspases , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[55] Ruedi Aebersold,et al. Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.
[56] J C Reed,et al. IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.
[57] Lars E. French,et al. The TRAIL to selective tumor death , 1999, Nature Medicine.
[58] P. Marrack,et al. Type I Interferons Keep Activated T Cells Alive , 1999, The Journal of experimental medicine.
[59] E. Feigal. AIDS-associated malignancies: research perspectives. , 1999, Biochimica et biophysica acta.
[60] E. Reddy,et al. Modulation of life and death by the TNF receptor superfamily , 1998, Oncogene.
[61] B. Williams,et al. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .
[62] T. Mak,et al. Activation of the dsRNA‐dependent protein kinase, PKR, induces apoptosis through FADD‐mediated death signaling , 1998, The EMBO journal.
[63] D. Levy,et al. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation , 1998, Nature.
[64] D. Levy,et al. Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7 , 1998, The EMBO journal.
[65] M. Coffey,et al. Reovirus therapy of tumors with activated Ras pathway. , 1998, Science.
[66] Martin Raff,et al. Cell suicide for beginners , 1998, Nature.
[67] M. Koken,et al. PML induces a novel caspase-independent death process , 1998, Nature Genetics.
[68] P. Pandolfi,et al. Pml is essential for multiple apoptotic pathways , 1998, Nature Genetics.
[69] J P Luzio,et al. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. , 1998, Science.
[70] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[71] C. Thompson,et al. Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death. , 1998, Genes & development.
[72] T. Taniguchi,et al. Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1. , 1998, European cytokine network.
[73] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[74] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[75] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[76] Xiaodong Wang,et al. Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.
[77] J. Darnell. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[78] P. Moore,et al. Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth. , 1998, Biochimie.
[79] P. Freemont,et al. The Disruption of ND10 during Herpes Simplex Virus Infection Correlates with the Vmw110- and Proteasome-Dependent Loss of Several PML Isoforms , 1998, Journal of Virology.
[80] M. Vidal,et al. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. , 1998, Genes & development.
[81] J. Dichgans,et al. Interferon-α enhances CD95L-induced apoptosis of human malignant glioma cells , 1998, Journal of Neuroimmunology.
[82] J. Hardwick. Viral interference with apoptosis. , 1998, Seminars in cell & developmental biology.
[83] J. Hiscott,et al. Virus-Dependent Phosphorylation of the IRF-3 Transcription Factor Regulates Nuclear Translocation, Transactivation Potential, and Proteasome-Mediated Degradation , 1998, Molecular and Cellular Biology.
[84] R. Schreiber,et al. Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses , 1998, Cell.
[85] T. Maniatis,et al. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. , 1998, Molecular cell.
[86] P. Moore,et al. Regulation of Type I Interferon Gene Expression by Interferon Regulatory Factor-3* , 1998, The Journal of Biological Chemistry.
[87] R. Kaufman,et al. Phosphorylation of Eukaryotic Translation Initiation Factor 2 Mediates Apoptosis in Response to Activation of the Double-stranded RNA-dependent Protein Kinase* , 1998, The Journal of Biological Chemistry.
[88] T. Taniguchi,et al. Type I interferons are essential mediators of apoptotic death in virally infected cells , 1998, Genes to cells : devoted to molecular & cellular mechanisms.
[89] J. Hiscott,et al. The growing family of interferon regulatory factors. , 1997, Cytokine & growth factor reviews.
[90] Aseem Kumar,et al. Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases , 1997 .
[91] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[92] R. Silverman,et al. Interferon action and apoptosis are defective in mice devoid of 2′,5′‐oligoadenylate‐dependent RNase L , 1997, The EMBO journal.
[93] C. Rivas,et al. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. , 1997, Virology.
[94] R. Flavell,et al. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis , 1997, Molecular and cellular biology.
[95] J. Tschopp,et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.
[96] T. Taniguchi,et al. DNA damage-induced apoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1. , 1997, Leukemia.
[97] S. Der,et al. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[98] W. Harrington,et al. AZOTHYMIDINE AND INTERFERON-α ARE ACTIVE IN AIDS-ASSOCIATED SMALL NONCLEAVED CELL LYMPHOMA BUT NOT LARGE CELL LYMPHOMA: 94 , 1997 .
[99] A. Cuddihy,et al. Physical association between STAT1 and the interferon‐inducible protein kinase PKR and implications for interferon and double‐stranded RNA signaling pathways , 1997, The EMBO journal.
[100] P. Branton,et al. Regulation of apoptosis by viral gene products , 1997, Journal of virology.
[101] S. Korsmeyer,et al. Bax suppresses tumorigenesis and stimulates apoptosis in vivo , 1997, Nature.
[102] E. Cheng,et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[103] B. Williams,et al. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF‐1 and NF‐κB , 1997, The EMBO journal.
[104] T. Takizawa,et al. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection , 1996, Journal of virology.
[105] A. Lau,et al. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[106] W. Harrington,et al. Azothymidine and interferon-a are active in AIDS-associated small non-cleaved cell lymphoma but not large-cell lymphoma , 1996, The Lancet.
[107] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.
[108] T. Sternsdorf,et al. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). , 1996, European journal of biochemistry.
[109] R. Schreiber,et al. Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.
[110] D. Levy,et al. Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.
[111] A. Aguzzi,et al. Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.
[112] P. Pandolfi,et al. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. , 1995, Oncogene.
[113] T. Taniguchi,et al. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes , 1995, Nature.
[114] N. Sonenberg,et al. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. , 1995, Oncogene.
[115] M. Kaplan,et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. , 1995, The New England journal of medicine.
[116] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.
[117] T. McDonnell,et al. Induction of apoptotic cell death in non‐melanoma skin cancer by interferon‐α , 1995, International journal of cancer.
[118] D. Faller,et al. Platelet-derived Growth Factor Signal Transduction through the Interferon-inducible Kinase PKR , 1995, The Journal of Biological Chemistry.
[119] A. Fauci,et al. Apoptosis in HIV infection , 1995, Nature Medicine.
[120] M. Katze. Regulation of the interferon-induced PKR: can viruses cope? , 1995, Trends in microbiology.
[121] M. Levitt,et al. Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. , 1995, Journal of the National Cancer Institute.
[122] A. Hinnebusch. The eIF-2α kinases: regulators of protein synthesis in starvation and stress , 1994 .
[123] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[124] T. Taniguchi,et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1 , 1994, Cell.
[125] S. B. Lee,et al. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. , 1994, Virology.
[126] M. Rowe,et al. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[127] M. Katze,et al. Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[128] C. Samuel,et al. The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. , 1993, The Journal of biological chemistry.
[129] Robert H. Silverman,et al. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.
[130] John Calvin Reed,et al. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene , 1993, Nature.
[131] M. Katze,et al. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. , 1992, Science.
[132] K. Schappert,et al. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. , 1992, The EMBO journal.
[133] Atsushi Hase,et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.
[134] I. Kerr,et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.
[135] I. kerr. The 2-5A system: a personal view. , 1987, Journal of interferon research.
[136] P. Lengyel,et al. Double-stranded RNA and interferon action. , 1987, Journal of interferon research.
[137] E. De Clercq,et al. Specificity of interferon-induced enhancement of toxicity for double-stranded ribonucleic acids. , 1973, The Journal of general virology.
[138] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[139] E. De Clercq,et al. Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[140] J. Lindenmann,et al. Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.
[141] K. Vousden,et al. Role of NF-kappaB in p53-mediated programmed cell death. , 2000, Nature.
[142] C Gélinas,et al. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). , 2000, Molecular and cellular biology.
[143] M. Gerotto,et al. The molecular basis for responsiveness to anti-viral therapy in hepatitis C. , 2000, Forum.
[144] P. Branton,et al. Viruses and apoptosis. , 1999, Annual review of microbiology.
[145] C. Biron,et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.
[146] L. Boise,et al. Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. , 1999, Cancer research.
[147] A. Cuddihy,et al. Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. , 1999, Molecular and cellular biology.
[148] J. Hiscott,et al. Triggering the interferon response: the role of IRF-3 transcription factor. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[149] R. Nasr,et al. Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. , 1999, Blood.
[150] G. Nolan,et al. NF-kappaB to the rescue: RELs, apoptosis and cellular transformation. , 1999, Trends in genetics : TIG.
[151] G. Barber,et al. PKR, apoptosis and cancer. , 1999, The international journal of biochemistry & cell biology.
[152] M. Tomonaga,et al. Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death. , 1999, Experimental hematology.
[153] L. Hood,et al. Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. , 1999, Oncogene.
[154] B. Williams,et al. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[155] J. Dichgans,et al. Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells. , 1998, Journal of neuroimmunology.
[156] V. Dixit,et al. Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. , 1998, Immunology today.
[157] Marty W. Mayo,et al. NF-k B Antiapoptosis : Induction of TRAF 1 and TRAF 2 and c-IAP 1 and c-IAP 2 to Suppress Caspase-8 Activation , 1998 .
[158] M. Peter,et al. AIDS and the death receptors. , 1997, British medical bulletin.
[159] I. Krantz,et al. KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene , 1997, Nature Genetics.
[160] G. Stark,et al. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. , 1997, Science.
[161] J. Hardwick. Virus-induced apoptosis. , 1997, Advances in pharmacology.
[162] Hardwick Jm. Virus-induced apoptosis. , 1997 .
[163] M. Mathews. Structure, function, and evolution of adenovirus virus-associated RNAs. , 1995, Current topics in microbiology and immunology.
[164] A. Hinnebusch. The eIF-2 alpha kinases: regulators of protein synthesis in starvation and stress. , 1994, Seminars in cell biology.
[165] M. Katze,et al. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.